Access the full text.
Sign up today, get DeepDyve free for 14 days.
10.2478/chilat-2014-0008 ORIGINAL ARTICLE Jekabs Krastins*, Zane Straume*, Janis Auzins*, Aigars Petersons**, Aivars Petersons*** *Pediatric Intensive Care, University Children's Hospital, Riga, Latvia **Department of Pediatric Surgery, Riga Stradin's University, Latvia ***Centre of Nephrology, Department of Internal diseases, Riga Stradin's University, Latvia Summary. Introduction. Cardiac surgery with cardiopulmonary bypass (CPB) is commonly perceived as a risk factor for decline in renal function. Hypothermia, hypoxia, hypotension, non-pulsatile blood flow during CPB, use of ACE inhibitors, inotropic and (or) vasoactive support affects kidney and contributes to the acute kidney injury (AKI). Aim of the study. The purpose of this study was to evaluate the incidence, severity and outcome of CPB related AKI in children after open heart surgery. Materials and methods. We conducted prospective, non-randomized observational study at the tertiary care University Children's Hospital Pediatric ICU. We enrolled 30 patients, 12 boys and 18 girls with congenital heart disease (CHD). Their median body weight was 6,8 kg, (IQR 5,2<8,2 kg) and median age 7 months (IQR 5<10 months). SCr was determined and preoperative and postoperative creatinine clearance (ClCr) was estimated using Schwarz formula (eClCr). During surgical repair and till the end of the first 12 postoperative hours urine was collected to measure ClCr, using the difference in urine (UCr) and SCr concentrations (mClCr). Urine output, body temperature, duration of aortic cross clamping and cardiopulmonary bypass was recorded. Results. Median intraoperative urine output was 2,4 ml/kg/h (IQR 1,29<3,15 ml/kg/h). Median CPB time was 147 min., (IQR 116,75<205 min.), median aortic cross-clamping time was 95 min., (IQR 70,5<133 min.), cooling during CPB to 29,75°C. Postoperative SCr increased to 35 mol/l (IQR 27,5<50,5 mol/l) vs. preoperative SCr 29 mol/l (IQR 24<32,9 mol/l), P<0,0001. GFR declined from preoperative 98,4 ml/min./1,73 m2 (IQR 89,6<123,04) to postoperative 80,98 ml/min./1,73 m2, (IQR 60,73<97,97 ml/min./1,73 m2), P<0,0001. We find statistically significant difference (P=0,042) in measured 39,88 ml/min./1,73 m2 (IQR 21,96<67,82 ml/min./1,73 m2) versus estimated ClCr (eClCr) 80,98 ml/min./1,73 m2, (IQR 60,73<97,97 ml/min./1,73 m2). Observed prevalence of AKI was 46,6% (14/30 patients met KDIGO criteria for AKI). Conclusions. Open heart surgery in children has severe, but transient effect on expression of renal biomarkers. There was a marked difference between measured and estimated ClCr in our patients. Observed incidence of AKI was 46,6% (14 patients met KDIGO criteria of AKI from 30 of our patients). Before discharge from the hospital both biomarkers returned to normal values. Keywords: cardiopulmonary bypass, acute kidney injury, renal biomarkers, creatinine clearance, pediatric open heart surgery. INTRODUCTION Cardiac surgery with cardiopulmonary bypass (CPB) is commonly perceived as a risk factor for decline in renal function. Acute kidney injury (AKI), depending on the specific definition, occurs in up to 52% of all patients who undergo open heart surgery (1-15). Renal replacement therapy (RRT) needs approximately 1% of patients suffering from AKI (1, 2, 4). The development of kidney injury is associated with a high mortality, a more complicated hospital course, and a higher risk for infectious complications (2). AKI has a notable increased morbidity risk, including longer duration of ventilation and overall length of stay (12). Even minimal changes in serum creatinine that occur in the postoperative period are associated with a substantial decrease in survival (10). Furthermore, the majority of patients who develop AKI that requires dialysis, remain dialysis dependent, leading to significant long-term morbidity and mortality (13). Pediatric patients comprise an ideal and informative population for the study of AKI biomarkers as they do not exhibit common adult confounding factors that complicate similar studies in adults, such as diabetes, hypertension, atherosclerosis, and nephrotoxin use (15). AIM OF THE STUDY Our goal was to evaluate incidence and outcome of AKI in children undergoing open heart surgery and to compare the measured and estimated ClCr. As an indicator of AKI we used perioperative changes in serum creatinine (SCr). KDIGO (Kidney Disease: Improving Global Outcomes) definition was used to assess severity of AKI. MATERIALS AND METHODS We conducted prospective, nonrandomized observational study at the tertiary care University Children's hospital 12-bed surgical ICU during 20102011 years. Study protocol was approved by Hospital Ethics commission. Inclusion criteria: Body weight less than 10 kg (1) and intact renal functions (2). We enrolled 30 patients, 12 boys and 18 girls with CHD. Their median body weight was 6,8 kg, (IQR 5,2<8,2 kg) and median age of 7 months (Table 1). There were 15 (50%) patients with ventricular septal defect (VSD), 7 (23,4%) patients had atrioventricular septal defect (AVSD), one (3,3%) had total anomalous pulmonary venous drainage (TAPVD), 3 (10%) had Tetrology of Fallot (TOF), 3 (10%) had transposition of great arteries (TGA), and one (3,3%)-AVSD with tricuspid stenosis (Table 2). The SCr level was determined by Jaffé's method (Cobas 6000 analyzer, Roche) and preoperative and postoperative ClCr without urine collection was estimated using Schwarz formula : eCrCl in ml/min/1,73 m2 = k × L/SCr, in which k is proportionality constant (0,33-0,45, depending on maturity) and L is length in centimeters. During the surgical repair and till the end of the first 12 hours after surgery urine was collected to measure ClCr, using the difference in urine (UCr) and SCr concentrations, using standard formula: mCrCl in ml/min/1,73 m2 = (UCr × Urine output (ml)/(SCr × time in hours × 60) × (1,73/BSA), in which UCr is urinary creatinine, SCr is serum creatinine and BSA is body surface area. Urine output, lowest body temperature during CPB, aortic cross clamping and cardiopulmonary bypass time was recorded. Statistical methods. Statistics were performed with the help of the statistical software StatPlus® 184.108.40.206 (Analyst Soft Inc). Continuous variables were presented as median and interquartile range (IQR). Dispersion analysis using one-way analysis of variance (ANOVA) test was used to determine the difference between SCr and ClCr values at different time points: Before the surgery (1), on the following morning,<12 hours after completion of surgery (2) and before discharge the patient from hospital (3). Continuous data were compared using Student's t-test. Pearsons correlation was used to find a correlation between CPB and ClCr. A p value less than 0,05 was considered statistically significant. RESULTS Median CPB time was 147 min., IQR 116,75<205 min., median aortic cross-clamping time was 95 min., (IQR 70,5<133 min.), cooling during CPB to 29,75°C. Median perioperative (from the start of surgery till the following morning <12 hours) urine output was 2,4 ml/kg/h (IQR 1,29<3,15 ml/kg/h), table 3. Postoperative median SCr raised to 35 mol/l (IQR 27,5<50,5) versus preoperative median SCr 29 mol/l (IQR 24<32,9), P<0,0001. GFR declined from preoperative 98,4 ml/min./1,73 m2 (IQR 89,6<123,04) to postoperative 80,98 ml/min./1,73 m2, (IQR 60,73<97,97 ml/min./1,73 m2), P<0,0001, (Table 4, Fig. 1,2). We find statistically significant difference (P=0,042) in measured 39,88 ml/min./1,73 m2, (IQR 21,96<67,82 ml/min./1,73 m2) ClCr and estimated ClCr (eClCr) 80,98 ml/min./1,73 m2 (IQR 60,73<97,97 ml/ min./1,73 m2). Schwarz equitation overestimates eClCr (80,98 vs. 39,88 ml/min./1,73 m2 (Fig. 3). According to KDIGO definition we detected AKI in 14/30 (46,6%) of our patients (Table 5). DISCUSSION The etiology of AKI after CPB is multifactorial and incompletely understood. Various factors related to CPB have been implicated as possible determinants of AKI. They include hypothermia, hypoxia, hypotension, nonpulsatile blood flow during CPB, use of ACE inhibitors, inotropic and (or) vasoactive support that affects kidney and contributes to the AKI. CPB is associated with significant hemodynamic changes, and the maintenance of cardiovascular stability during CPB requires interplay between the function of the CPB machine and patient factors such as systemic vascular resistance, venous compliance, and autoregulatory capacity of various vascular beds. CPB creates a hemodynamic state of nonpulsatile flow and microembolism. Hemodynamic instability may occur during the transition from full hemodynamic support with CPB to full circulation by the patient's own cardiovascular system. A low-cardiac output state contributes to generalized hypoperfusion and renal ischemia. Length of time on CPB is a wellrecognized risk factor for the development of AKI. The ultimate goal is to maintain regional perfusion at a level that supports optimal cellular and organ function. Thus, any decrease in renal perfusion during CPB, depending on its magnitude and duration, can lead to significant cellular injury. The pathogenesis of cardiac surgery-associated AKI is complex and multifactorial and includes several injury pathways: ischemia and reperfusion, exogenous and endogenous toxins, inflammation, oxidative stress, and hemodynamic factors. These mechanisms of injury are likely to be active at different times with different intensities and probably act synergistically (17). The reported incidence of AKI after pediatric open heart surgery varies from 1,6% to 52% depending on definition. To amend this variability, the Acute Dialysis Quality Initiative group standardized the definition of AKI in 2002 using the RIFLE criteria (18). Based on glomerular filtration rate, serum creatinine values, and urine output plotted against time of admission, RIFLE marks progressive degrees of injury in adult patients. In 2004, the Acute Kidney Injury Network defined AKI based on time in relation to absolute creatinine increase, percentage increase, or documented oliguria. The adult-derived RIFLE definition was modified, applied, and validated in studies of critically ill patients (19) and renamed the pediatric RIFLE (pRIFLE) criteria (20). Recently the KDIGO workgroup has reviewed these criteria and published a single definition for use in both clinical practice and research. AKI is defined when any of the following three criteria are met; an increase in serum creatinine by 50%, an increase in serum creatinine>0.3 mg/dL or oliguria (21). In the study conducted by Liu and colleagues (14) defined AKI was a 50% or greater increase in serum creatinine from baseline within 3 days. Of the 71 pediatric patients undergoing open heart surgery, AKI developed in 20 patients (28%). Krawczeski with coauthors (13) in study of 240 pediatric patients, AKI occurred in 27% of them. Patients having AKI were younger and had lower baseline SCr. None of their patients required RRT. AKI was associated with longer CPB times (P=0,0005) and increased need for mechanical ventilation, 33% versus 78% (P=0,006) in patients having AKI. In Bennett's study (8) AKI developed in 99 patients (51%). Blinder with colleagues (9) retrospectively studied 430 infants who underwent heart surgery for congenital defects and observed AKI in 52% of patients. Even in the studies published after introduction of RIFLE and AKIN definitions, variability (27%-52%) of AKI incidence has been reported (5,6,8,9,15). It was difficult to compare SCr and ClCr values of various ages due to wide distribution of specific values. ClCr vary from 17 ml/min/1,73 m2 in the first week of life to 157 ml/min/1,73 m2 at 12 months of age (22). To overcome this difficulty we based our study on SCr dynamics (1,5, 2 fold and 3 fold rise in SCr against entry level corresponds to stages 1, 2, and 3 in KDIGO definition (21). In our study group AKI criteria met 46,6% (14/30) of our patients. SCr increase by 50%100% (Median 65,22 mol/l) we detected in 9 patients, more than 2-fold increase in SCr (Median 228,88 mol/l) we find in 5 children (Table 5). In current clinical practice SCr is used for identification and classification of AKI as an essential reference in all AKI definitions. Last years a number of new, more sensitive biomarkers of kidney injury are introduced, tested and validated (23). Kidney injury molecule-1, interleukin-18, and liver fatty acid-binding protein (L-FABP) have been shown to be associated with kidney ischemia (13). Clinical studies indicate urine and serum neutrophil gelatinase-associated lipocalin as highly sensitive, specific, and predictive of AKI in many different disease processes (14). Recently, urinary hepcidin has been suggested as a candidate biomarker of AKI (24). Despite the enthusiasm with novel biomarkers, most of them are still not available for routine clinical practice. In the postoperative care ClCr based estimate of GFR still may be a good biomarker of change in renal function (25). Until recently, most AKI studies have focused on critically ill children who receive some form of RRT. While care for the critically ill child with AKI has improved greatly, with survival rates reaching 6070% for children who require renal replacement therapy (26), few data exist to describe the long-term outcomes of survivors of a pediatric AKI episode. Finally, at 3- to 5-year followup, 40% to 50% of pediatric patients who had AKI show signs of chronic renal insufficiency, indicating that sublethal injury permanently alters the renal bed (27). We observed normalization of both markers (SCr and ClCr) before discharge patient from the hospital. Our finding of the marked difference in estimated ClCr (eClCr) and measured ClCr (mClCr) 80,98 vs. 39,88 ml/min./1,73 m2 are consistent with results published by Harrison MA. et al. (28). They studied 14 neonates undergoing open heart surgery and find that the median overestimation of ClCr by the Schwartz formula was 58%. The difference between mClCr and eClCr authors explain due to diminished renal blood flow, postoperative ventricular dysfunction, reperfusion injury, and the systemic inflammatory response triggered by CPB. Evidence supports an independent association between the duration of CPB and the development of CPB related AKI (28). In general, the longer the duration of extracorporeal support, the higher the risk of coagulopathy, the need for transfusion support, gut hypoperfusion, renal ischemia and AKI. There is no single defined threshold time during CPB beyond which the incidence of AKI increases dramatically. Future studies may better define a safe time limit during CPB to decrease perfusion related AKI. CONCLUSIONS Open heart surgery is associated with a high risk for developing AKI. This complication is associated further with substantial morbidity and mortality. The pathogenesis of kidney injury during CPB is complex and involves hemodynamic, inflammatory, and other mechanisms that interact at a cellular level. At present, no pharmacologic interventions have demonstrated conclusively efficacy in the prevention of renal dysfunction after cardiac surgery. More important is to prevent development of AKI preserving autoregulation of renal perfusion to avoid ischemic injury. The incidence of AKI in our group of patients according the KDIGO definition was 46,6% (14/30), however they did not require application of any form of RRT. Schwartz formula overestimates ClCr and reliance on eClCr could result in toxic concentrations of drugs eliminated by the kidneys. Short-time outcome (till one months) shows that in the population studied, these changes have a severe, but transient effect and renal biomarkers (SCr and ClCr) return to normal values at the time of discharge the patient from hospital. Conflict of interest: None REFERENCES: 1. Rigden SPA , Barratt TM, Dillon MJ (1982) Acute renal failure complicating cardiopulmonary bypass surgery. Arch Dis in Childh;57, 425-430 Giuffre RM, Tam KH, Williams WW et al (1992) Acute renal failure complicating pediatric cardiac surgery: A comparison of survivors and nonsurvivors following acute peritoneal dialysis. Pediatr Cardiol;13:208213 Dittrich S, Kurschat K, Dähnert I et al (2000) Renal function after cardiopulmonary bypass surgery in cyanotic congenital heart disease. Int Journ of Cardiol;73:2, 173-179 Kist-van Holthe tot Echten JE, Goedvolk CA, Doornaar van der Vorst MMJ et al (2001) Acute renal insufficiency and renal replacement therapy after pediatric cardiopulmonary bypass surgery. Pediatr Cardiol; 22:321326 Mishra J, Dent C, Tarabishi R et al (2005) Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery Lancet; 365:12311238 Skippen PW, Krahn GE (2005) Acute Renal Failure in Children Undergoing Cardiopulmonary Bypass. Crit Care Resusc;7:286291 Kuitunen A, Vento A, Suojaranta-Ylinen R et al (2006) Acute Renal Failure After Cardiac Surgery: Evaluation of the RIFLE Classification. Ann Thorac Surg;81:542546. Bennett M, Dent CL, Ma Q, et al (2008) Urine NGAL Predicts Severity of Acute Kidney Injury After Cardiac Surgery: A Prospective Study. Clin J Am Soc Nephrol:3: 665-673 Blinder JJ, Goldstein SL, Lee VV et al (2012) Congenital heart surgery in infants: Effects of acute kidney injury on outcomes. J Thorac Cardiovasc Surg;143:368-374 Zappitelli M, Bernier P-L, Saczkowski RS et al (2009) A small post-operative rise in serum creatinine predicts acute kidney injury in children undergoing cardiac surgery. Kidney Int; 76, 885892 Goldstein SL, Chang AC (2006) Fluid balance in children after cardiac surgery: Is fenoldopam an answer? Pediatr Crit Care Med;7:89-90 Picca S, Principato F, Mazzera E et al (1995) Risks of acute renal failure after cardiopulmonary bypass surgery in children: a retrospective 10-year casecontrol study. Nephrol Dial Transplant;10:630-636 Krawczeski CD, Goldstein SL, Woo JG et al (2011) Temporal Relationship and Predictive Value of Urinary Acute Kidney Injury Biomarkers After Pediatric Cardiopulmonary Bypass. JACC; 58:22,23012309 Liu KD, Altmann C, Smits G et al (2009) Serum interleukin-6 and interleukin-8 are early biomarkers of acute kidney injury and predict prolonged mechanical ventilation in children undergoing cardiac surgery: a case-control study. (2009) Crit Care;13:R104 Beger RD, Holland RD, Sun J et al (2008) Metabonomics of acute kidney injury in children after cardiac surgery. Pediatr Nephrol;23:977984 Schwartz GJ, Muñoz A, Schneider MF et al (2009) New Equations to Estimate GFR in Children with CKD. J Am Soc Nephrol; 20(3):629637 Bellomo R, Auriemma S, Fabbri A, et al (2008) The pathophysiology of cardiac surgery-associated acute kidney injury (CSA-AKI). Int J Artif Organs;31:1 66 78. Bellomo R, Ronco C, Kellum JA et al (2004) Acute renal failure - Definition, outcome measures, animal models, fluid therapy and information technology needs: The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care; 8:R204R212 Palmieri T, Lavrentieva A, Greenhalgh D (2009) An assessment of acute kidney injury with modified RIFLE criteria in pediatric patients with severe burns. Intensive Care Med; 35:21252129 Akcan-Arikan A, Zappitelli M, Loftis LL et al (2007) Modified RIFLE criteria in critically ill children with acute kidney injury. Kidney Int;71,1028-1035 21. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. (2012) KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney inter, Suppl.; 2: 1138 22. Heilbron DC, Holliday MA, AI-Dahwi A et al (1991) Expressing glomerular filtration rate in children. Pediatr Nephrol;5:5-11 23. Zaffanello M, Franchini M, Fanos V (2007) Is Serum Cystatin-C a Suitable Marker of Renal Function in Children? Ann Clin Lab Sci;37:233-239 24. Ho J, Lucy M, Krokhin O et al. (2009) Mass spectrometry-based proteomic analysis of urine in acute kidney injury following cardiopulmonary bypass: a nested case-control study. Am J Kidney Dis; 53:584595 25. Sear JW (2005) Kidney dysfunction in the postoperative period. Brit Journ of Anaesth; 95:20 32 26. Uchino S, Kellum JA, Bellomo R et al (2005) Acute renal failure in critically ill patients: A multinational, multicenter study. JAMA; 294:813818 27. Askenazi DJ, Feig DI, Graham NM et al (2006) 35 year longitudinal follow-up of pediatric patients after acute renal failure. Kidney Int; 69:184189 28. Harrison MA, Davis S, Eggleston S et al (2003) Serum creatinine and estimated creatinine clearance do not predict perioperatively measured creatinine clearance in neonates undergoing congenital heart surgery. Pediatr Crit Care Med;4:55-59 29. Salis S, Mazzanti VV, Salvi L et al (2008) Cardiopulmonary bypass duration is an independent predictor of mortality and morbidity after cardiac surgery. J Cardiothorac Vasc Anesth;22:814 822 Address: Jekabs Krastins Department of Pediatric Intensive Anaesthesiology, Children`s University Hospital, Vienibas gatve 45, Riga E-mail: email@example.com Care and Table 1. Demographic data Variable Age, months Body weight (kg) Median 7,5 6,4 IQR 5<10 5,2<8,2 Range 0,3<26 2,88<10 Table 2. Characteristics of patients Heart leason AVSD (Atrioventricular septal defect) ASD (Atrial septal defect) VSD (Ventricular septal defect) TAPVD (Total anomalous pulmonary vein drainage) TGA (Transposition of great arteries) TOF (Tetralogy of Fallot) Total: No of pts 7 1 15 1 3 3 30 % 23,4 3,3 50,0 3,3 10,0 10,0 100,0 Table 3. CPB variables Variable CPB time (min.) Aortic cross-clamping time (min.) Lowest body temperature (C°) Urine output (ml/kg/h) Median 147 95 29,75 2,41 IQR 116,75<205 70,5<133 27,48<30,83 1,29<3,15 Range 50<286 25<185 19<32 0,47<7,76 Table 4. Perioperative changes in SCr and CrCl Variable SCr (mol/l) eClCr (ml/min./1,73 m2) mClCr (ml/min./1,73 m2) * mClCr versus eClCr (Fig. 3) Before surgery 29 (24<32,9) 98,43 (89,57<123,04) After CPB 35 (27,5<50,5) 80,98 (60,73<97,97) 39,88 (21,96<67,82) Before discharge 23 (19,3<26,75) 124,80 (104,25<145,24) P <0,0001 <0,0001 0,0042* Table 5. Incidence af AKI according to KDIGO criteria. Variable (Median [IQR]) SCr increase Absolute in mol/l Rise (%) from baseline Stage I (n=9) 15,00 (11,2<24,68) 65,22 (58,26<83,45) Stage II and III (n=5) 38,91 (28,90<52,34) 228,88 (139,40<266,64) Fig. 1 120 100 SCr µg/l 80 60 40 20 0 SCr I Changes in SCr P<0,0001 SCr II SCr III Fig. 2 P<0,0001 Dynamics of eClCr eClCr ml/min./m2 eClCr I eClCr II eClCr III Fig. 3 200 180 ClCr ml/min./1,73 m2 160 140 120 100 80 60 40 20 0 Estimated ClCr vs. measured ClCr P=0,0042 mClCr eClCr
Acta Chirurgica Latviensis – de Gruyter
Published: Dec 1, 2013
Access the full text.
Sign up today, get DeepDyve free for 14 days.